focus
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: FDA authorizes Novavax’s updated Covid
Next article: FDA authorizes Novavax’s updated Covid
knowledge
focus
-
3 questions for the future of Biden's cancer moonshot
2025-08-23 06:32 -
Histogen: Failed biotech offers rare public look inside
2025-08-23 06:17 -
ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
2025-08-23 05:24 -
FDA rejects Alnylam's heart disease treatment over insufficient data
2025-08-23 05:10 -
HIV drugs protect against transmission, even in unprotected sex
2025-08-23 05:10 -
Was Amgen transparent enough on FDA's concern on cancer drug?
2025-08-23 04:40